North America Gastroparesis Market
Historic Data:    |   Base Year: 2023   |   Forecast Period: 2024-2031
Forecast to 2027 - COVID-19 Impact and Regional Analysis By Type (Idiopathic, Diabetic, Post-Surgical, and Others), Drug Class (Prokinetic Agents, Botulinum Toxin Injections, and Antiemetic Agents), and Distribution Channel (Retail Pharmacies, Hospital Pharmacies, and Others)

No. of Pages: 115    |    Report Code: TIPRE00024816    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
North America Gastroparesis Market
Free Sample Buy Now

1. Introduction

1.1 Business Market Insights Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights
2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
  • 3.2.1 Hypothesis formulation:
  • 3.2.2 Macro-economic factor analysis:
  • 3.2.3 Developing base number:
  • 3.2.4 Data Triangulation:
  • 3.2.5 Country level data:

4. North America Gastroparesis Market Landscape

4.1 Market Overview
4.2 Porter's Five Forces Analysis
  • 4.2.1 Bargaining Power of Suppliers
  • 4.2.2 Bargaining Power of Buyers
  • 4.2.3 Threat of New Entrants
  • 4.2.4 Competitive Rivalry
  • 4.2.5 Threat of Substitutes
4.3 Ecosystem Analysis
  • 4.3.1 Raw Material Suppliers
  • 4.3.2 Manufacturers
  • 4.3.3 Distributors/Suppliers
  • 4.3.4 End Users

5. North America Gastroparesis Market – Key Market Dynamics

5.1 Growth Drivers
  • 5.1.1 Increasing prevelance of Diabetes Mellitus
5.2 Market Opportunities
  • 5.2.1 Surging Clinical Trials
5.3 Future Trends
  • 5.3.1 Technological Advancements and incresaing research on gastric stimulation
5.4 Impact of Drivers and Restraints

6. North America Gastroparesis Market Regional Analysis

6.1 North America Gastroparesis Market Overview
6.2 North America Gastroparesis Market Revenue 2018-2027 (US$ Million)
6.3 North America Gastroparesis Market Forecast Analysis

7. North America Gastroparesis Market Analysis – by Type

7.1 Idiopathic
  • 7.1.1 Overview
  • 7.1.2 Idiopathic: North America Gastroparesis Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Diabetic
  • 7.2.1 Overview
  • 7.2.2 Diabetic: North America Gastroparesis Market – Revenue and Forecast to 2031 (US$ Million)
7.3 Post-Surgical
  • 7.3.1 Overview
  • 7.3.2 Post-Surgical: North America Gastroparesis Market – Revenue and Forecast to 2031 (US$ Million)

8. North America Gastroparesis Market Analysis – by Drug Class

8.1 Prokinetic Agents
  • 8.1.1 Overview
  • 8.1.2 Prokinetic Agents: North America Gastroparesis Market – Revenue and Forecast to 2027 (US$ Million)
8.2 Botulinum Toxin Injections
  • 8.2.1 Overview
  • 8.2.2 Botulinum Toxin Injections: North America Gastroparesis Market – Revenue and Forecast to 2027 (US$ Million)
8.3 Antiemetic Agents
  • 8.3.1 Overview
  • 8.3.2 Antiemetic Agents: North America Gastroparesis Market – Revenue and Forecast to 2027 (US$ Million)

9. North America Gastroparesis Market Analysis – by Distribution Channel

9.1 Retail Pharmacies
  • 9.1.1 Overview
  • 9.1.2 Antiemetic Agents: North America Gastroparesis Market – Revenue and Forecast to 2027 (US$ Million)
9.2 Hospital Pharmacies
  • 9.2.1 Overview
  • 9.2.2 Antiemetic Agents: North America Gastroparesis Market – Revenue and Forecast to 2027 (US$ Million)

10. North America Gastroparesis Market – North America Analysis

10.1 North America
  • 10.1.1 North America Gastroparesis Market Breakdown, by Key Country, 2021 and 2027 (%)
  • 10.1.1.1 North America Gastroparesis Market – Revenue and Forecast Analysis – by Country
  • 10.1.1.1 US: North America Gastroparesis Market – Revenue and Forecast to 2027 (US$ Million)
    • 10.1.1.1.1 US: North America Gastroparesis Market Breakdown, by Type
    • 10.1.1.1.2 US: North America Gastroparesis Market Breakdown, by Drug Class
    • 10.1.1.1.3 US: North America Gastroparesis Market Breakdown, by Distribution Channel
  • 10.1.1.2 Canada: North America Gastroparesis Market – Revenue and Forecast to 2027 (US$ Million)
    • 10.1.1.2.1 Canada: North America Gastroparesis Market Breakdown, by Type
    • 10.1.1.2.2 Canada: North America Gastroparesis Market Breakdown, by Drug Class
    • 10.1.1.2.3 Canada: North America Gastroparesis Market Breakdown, by Distribution Channel
  • 10.1.1.3 Mexico: North America Gastroparesis Market – Revenue and Forecast to 2027 (US$ Million)
    • 10.1.1.3.1 Mexico: North America Gastroparesis Market Breakdown, by Type
    • 10.1.1.3.2 Mexico: North America Gastroparesis Market Breakdown, by Drug Class
    • 10.1.1.3.3 Mexico: North America Gastroparesis Market Breakdown, by Distribution Channel

11. Competitive Landscape

11.1 Heat Map Analysis
11.2 Company Positioning and Concentration

12. North America Gastroparesis Market Industry Landscape

12.1 Overview
12.2 Mergers and Acquisitions
12.3 Agreements, Collaborations, and Joint Ventures
12.4 New Product Launches
12.5 Expansions and Other Strategic Developments

13. Company Profiles

13.1 Allergan Plc
  • 13.1.1 Key Facts
  • 13.1.2 Business Description
  • 13.1.3 Products and Services
  • 13.1.4 Financial Overview
  • 13.1.5 SWOT Analysis
  • 13.1.6 Key Developments
13.2 ANI Pharmaceuticals, Inc.
  • 13.2.1 Key Facts
  • 13.2.2 Business Description
  • 13.2.3 Products and Services
  • 13.2.4 Financial Overview
  • 13.2.5 SWOT Analysis
  • 13.2.6 Key Developments
13.3 Bausch Health Companies Inc. (Salix Pharmaceuticals, Ltd.)
  • 13.3.1 Key Facts
  • 13.3.2 Business Description
  • 13.3.3 Products and Services
  • 13.3.4 Financial Overview
  • 13.3.5 SWOT Analysis
  • 13.3.6 Key Developments
13.4 Cinrx Pharma, LLC (Cindome Pharma)
  • 13.4.1 Key Facts
  • 13.4.2 Business Description
  • 13.4.3 Products and Services
  • 13.4.4 Financial Overview
  • 13.4.5 SWOT Analysis
  • 13.4.6 Key Developments
13.5 EVOKE PHARMA
  • 13.5.1 Key Facts
  • 13.5.2 Business Description
  • 13.5.3 Products and Services
  • 13.5.4 Financial Overview
  • 13.5.5 SWOT Analysis
  • 13.5.6 Key Developments
13.6 Ipca Laboratories Ltd.
  • 13.6.1 Key Facts
  • 13.6.2 Business Description
  • 13.6.3 Products and Services
  • 13.6.4 Financial Overview
  • 13.6.5 SWOT Analysis
  • 13.6.6 Key Developments
13.7 Johnson and Johnson Services, Inc.
  • 13.7.1 Key Facts
  • 13.7.2 Business Description
  • 13.7.3 Products and Services
  • 13.7.4 Financial Overview
  • 13.7.5 SWOT Analysis
  • 13.7.6 Key Developments
13.8 NEUROGASTRX, INC.
  • 13.8.1 Key Facts
  • 13.8.2 Business Description
  • 13.8.3 Products and Services
  • 13.8.4 Financial Overview
  • 13.8.5 SWOT Analysis
  • 13.8.6 Key Developments
13.9 Pfizer Inc.
  • 13.9.1 Key Facts
  • 13.9.2 Business Description
  • 13.9.3 Products and Services
  • 13.9.4 Financial Overview
  • 13.9.5 SWOT Analysis
  • 13.9.6 Key Developments
13.10 TEVA PHARMACEUTICAL INDUSTRIES LTD
  • 13.10.1 Key Facts
  • 13.10.2 Business Description
  • 13.10.3 Products and Services
  • 13.10.4 Financial Overview
  • 13.10.5 SWOT Analysis
  • 13.10.6 Key Developments

14. Appendix

14.1 About Business Market Insights

The List of Companies - North America Gastroparesis Market

  1. Allergan Plc
  2. ANI Pharmaceuticals, Inc.
  3. Bausch Health Companies Inc. (Salix Pharmaceuticals, Ltd.)
  4. Cinrx Pharma, LLC (Cindome Pharma)
  5. EVOKE PHARMA
  6. Ipca Laboratories Ltd.
  7. Johnson and Johnson Services, Inc.
  8. NEUROGASTRX, INC.
  9. Pfizer Inc.
  10. TEVA PHARMACEUTICAL INDUSTRIES LTD
north-america-gastroparesis-market